Tumors of the Central Nervous System, Volume 1 [electronic resource] : Gliomas: Glioblastoma (Part 1) / edited by M. A. Hayat.
By: Hayat, M. A [editor.].
Contributor(s): SpringerLink (Online service).
Material type:
BookSeries: Tumors of the Central Nervous System: 1Publisher: Dordrecht : Springer Netherlands, 2011Description: XXII, 434 p. online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9789400703445.Subject(s): Medicine | Oncology | Radiology, Medical | Neurosurgery | Pathology | Surgery | Biomedicine | Cancer Research | Neuroradiology | Neurosurgery | Oncology | Pathology | SurgeryDDC classification: 614.5999 Online resources: Click here to access online
In:
Springer eBooksSummary: The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
There are no comments for this item.